E09.3541 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye

Name of the Condition

• Drug or Chemical Induced Diabetes Mellitus with Proliferative Diabetic Retinopathy with Combined Traction Retinal Detachment and Rhegmatogenous Retinal Detachment, Right Eye (ICD-10 Code: E09.3541)

Summary

This condition is a form of diabetes mellitus resulting from drug or chemical exposure, characterized by advanced diabetic eye disease. It involves proliferative diabetic retinopathy, where abnormal blood vessel growth in the retina leads to combined traction and rhegmatogenous retinal detachments in the right eye, potentially causing significant vision loss.

Causes

The condition is induced by exposure to drugs or chemicals that disrupt glucose metabolism, leading to uncontrolled hyperglycemia. These substances impair insulin regulation, triggering diabetes that progresses to proliferative diabetic retinopathy. The retinal detachments occur due to abnormal vascular growth and structural changes in the retina.

Risk Factors

• Use of medications or exposure to chemicals known to affect glucose metabolism.
• Pre-existing diabetes or family history of diabetes.
• Long-standing diabetes or poorly controlled blood sugar levels.
• Other risk factors for diabetic retinopathy, such as hypertension or kidney disease.

Symptoms

• Blurred vision or sudden vision loss in the right eye.
• Floaters or dark spots in the visual field of the right eye.
• Distorted or wavy vision in the right eye.
• Pain or redness in the right eye (less common).

Diagnosis

Diagnosis involves confirming drug or chemical-induced diabetes through clinical history and blood tests, followed by a comprehensive eye examination. Retinal imaging, such as optical coherence tomography (OCT) or fluorescein angiography, is used to assess proliferative diabetic retinopathy and retinal detachments in the right eye.

Treatment Options

Treatment focuses on managing blood sugar levels to slow retinopathy progression and addressing retinal detachments. Options may include laser therapy, vitrectomy surgery, or medications to reduce abnormal blood vessel growth. Close monitoring of the right eye is essential.

Prognosis and Follow-Up

Prognosis depends on the severity of retinal damage and response to treatment. Regular follow-up with an ophthalmologist is critical to monitor the right eye and prevent further vision loss. Early intervention improves outcomes.

Complications

Potential complications include permanent vision loss in the right eye, recurrent retinal detachments, or progression to other diabetic eye conditions. Untreated, the condition may lead to blindness.

Lifestyle & Prevention

Managing blood sugar levels through diet, exercise, and medication adherence can reduce retinopathy risk. Avoiding or discontinuing the causative drug/chemical, when possible, may prevent progression. Regular eye exams are recommended for early detection.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision loss, floaters, or pain in the right eye. Prompt evaluation is necessary to address retinal detachments and preserve vision.

Tips for Medical Coders

Document the specific eye (right eye) and the combined nature of the retinal detachments (traction and rhegmatogenous) to support accurate coding. Include details about the drug or chemical exposure and any diagnostic imaging findings. Ensure clinical documentation aligns with the code’s specificity.